HAP Wants to Let You Know of The Chantix Drug Recall
On September 16, 2021, Pfizer issued a recall for all brand Chantix products for safety reasons. These products are being recalled due to presence of a nitrosamine contaminate that may be associated with a theoretical potential for increase in cancer risk in humans.
HAP sent a letter to all impacted members. We also sent a letter to prescribers with a list of their HAP patients who received Chantix after May 1, 2021.
Click here to read the full announcement.